Pancreatic Polypeptide in Parkinson's Disease: A Potential Marker of Parasympathetic Denervation
Research output: Contribution to journal › Journal article › peer-review
Standard
Pancreatic Polypeptide in Parkinson's Disease : A Potential Marker of Parasympathetic Denervation. / Knudsen, Karoline; Hartmann, Bolette; Fedorova, Tatyana D; Østergaard, Karen; Krogh, Klaus; Møller, Niels; Holst, Jens J; Borghammer, Per.
In: Journal of Parkinson's Disease, Vol. 7, No. 4, 2017, p. 645-652.Research output: Contribution to journal › Journal article › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Pancreatic Polypeptide in Parkinson's Disease
T2 - A Potential Marker of Parasympathetic Denervation
AU - Knudsen, Karoline
AU - Hartmann, Bolette
AU - Fedorova, Tatyana D
AU - Østergaard, Karen
AU - Krogh, Klaus
AU - Møller, Niels
AU - Holst, Jens J
AU - Borghammer, Per
PY - 2017
Y1 - 2017
N2 - BACKGROUND AND OBJECTIVES: Parkinson's disease (PD) patients experience several non-motor symptoms from the gastrointestinal tract that may partly be caused by parasympathetic deficiency. The pancreas is densely innervated by the vagus nerve, which mediates early meal-induced secretion of pancreatic polypeptide (PP). Early secretion after sham feeding has been validated as a marker of vagal integrity. Thus, the aim was to evaluate the ratio of increased PP plasma levels after sham feeding in PD and correlate findings with gastrointestinal transit time (GITT).METHODS: Twenty-five PD patients and 17 controls were included. PP, insulin, and blood glucose levels were measured before, during, and after sham feeding with white bread and chocolate spread. GITT was measured using radiopaque markers. Furthermore, faeces samples were analyzed for pancreatic elastase enzyme as a marker of exocrine pancreatic function.RESULTS: PD patients showed significantly lower PP ratio levels after sham feeding, which was most pronounced at 10 minutes. No significant association was seen between attenuated PP response and GITT in PD patients. No between-group differences were seen in glucose or insulin levels over time, but PD patients showed generally lower insulin levels compared to controls. No difference was found in faeces pancreatic elastase.CONCLUSIONS: Early-to-moderate stage PD patients demonstrated significantly decreased PP response after sham feeding suggestive of vagal denervation.
AB - BACKGROUND AND OBJECTIVES: Parkinson's disease (PD) patients experience several non-motor symptoms from the gastrointestinal tract that may partly be caused by parasympathetic deficiency. The pancreas is densely innervated by the vagus nerve, which mediates early meal-induced secretion of pancreatic polypeptide (PP). Early secretion after sham feeding has been validated as a marker of vagal integrity. Thus, the aim was to evaluate the ratio of increased PP plasma levels after sham feeding in PD and correlate findings with gastrointestinal transit time (GITT).METHODS: Twenty-five PD patients and 17 controls were included. PP, insulin, and blood glucose levels were measured before, during, and after sham feeding with white bread and chocolate spread. GITT was measured using radiopaque markers. Furthermore, faeces samples were analyzed for pancreatic elastase enzyme as a marker of exocrine pancreatic function.RESULTS: PD patients showed significantly lower PP ratio levels after sham feeding, which was most pronounced at 10 minutes. No significant association was seen between attenuated PP response and GITT in PD patients. No between-group differences were seen in glucose or insulin levels over time, but PD patients showed generally lower insulin levels compared to controls. No difference was found in faeces pancreatic elastase.CONCLUSIONS: Early-to-moderate stage PD patients demonstrated significantly decreased PP response after sham feeding suggestive of vagal denervation.
KW - Journal Article
U2 - 10.3233/JPD-171189
DO - 10.3233/JPD-171189
M3 - Journal article
C2 - 28922171
VL - 7
SP - 645
EP - 652
JO - Journal of Parkinson's Disease
JF - Journal of Parkinson's Disease
SN - 1877-7171
IS - 4
ER -
ID: 189665071